An International Diabetes Perspective: Kyle Jacques Rose
Thank you for having invited me to say a few words. Last year, I visited over 20 different countries meeting with fellow patients with diabetes and speaking to key influencers in diabetes healthcare policy in the public and private sectors. Traveling as much as I do has allowed me to learn a great deal from my peers and helped me realize that we are perhaps not as different as I would have imagined.
Whether it’s Singapore, Abu Dhabi, Europe or the U.S., our needs are consistent. We want to lead healthy lives and minimize the added burden that diabetes brings to our daily routines. What is perhaps not so straight-forward are the environmental factors which impact our ability to do so.
My work is based on the principle that people should have access to medicine no matter where they live. In the case of poor countries, this means working with organizations who can supply medicine to meet basic health needs. Recently, I visited Life For A Child’s partner Vivir Con Diabetes Center in Cochabamba, Bolivia where insulin and test strips are provided to children who would otherwise die without them.
Elsewhere, it has meant working with healthcare payers (public and private) to provide access to treatments that would be otherwise cost-prohibitive to the diabetes community. The situation in the UK is a good example of a challenging environment. In my opinion, the National Health Service (NHS) is a very good overall healthcare system which has a lot to offer. However, patients have suffered in terms of access to devices such as insulin pumps and even blood glucose test strips sometimes due to limitations in funding. Local nonprofits such as INPUT and JDRF UK have helped me understand the seriousness of the problem. I will be addressing Members of Parliament in Westminster London next month and look forward to speaking on behalf of the many fellow diabetics I have met across the UK.
I feel privileged to have had access to a diabetes therapy that has enabled me to lead a healthy life. Insulin pump therapy and continuous glucose monitoring have not only reduced my risk for developing health complications, but they also have significantly increased my quality of life. I am extremely grateful and intend to keep speaking up about it until we can all share these same health benefits, no matter which borders we happen to live between.
- Medtronic Diabetes insulin infusion pumps, continuous glucose monitoring systems and associated components are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks associated with the use of these systems.
- Successful operation of the insulin infusion pumps and/or continuous glucose monitoring systems requires adequate vision and hearing to recognize alerts and alarms.
Medtronic Diabetes Insulin Infusion Pumps
- Insulin pump therapy is not recommended for individuals who are unable or unwilling to perform a minimum of four blood glucose tests per day.
- Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately.
Medtronic Diabetes Continuous Glucose Monitoring (CGM) Systems
- The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a home glucose meter. A confirmatory fingerstick is required prior to treatment.
- Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected.
For more information, please visit www.medtronicdiabetes.com/importantsafetyinformation.